2012 - Study ~ Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects.

2011 - Study ~ Gadolinium-HU-308-incorporated micelles.

2011 - Study ~ CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling

2008 - Study ~ Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor

2007 - Study ~ Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

2006 - Study ~ Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

2006 - News - Activation of CB2 receptor attenuates bone loss in osteoporosis

2005 - Study -  Peripheral cannabinoid receptor, CB2, regulates bone mass

2005 - Study ~ Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

2005 - Study ~ Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.

1999 - Study ~ HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.